154 related articles for article (PubMed ID: 33531212)
1. Engaging the justice system to address the opioid crisis: The Justice Community Opioid Innovation Network (JCOIN).
Ducharme LJ; Wiley TRA; Mulford CF; Su ZI; Zur JB
J Subst Abuse Treat; 2021 Sep; 128():108307. PubMed ID: 33531212
[TBL] [Abstract][Full Text] [Related]
2. Justice community opioid innovation network (JCOIN): The TCU research hub.
Knight D; Becan J; Olson D; Davis NP; Jones J; Wiese A; Carey P; Howell D; Knight K
J Subst Abuse Treat; 2021 Sep; 128():108290. PubMed ID: 33487517
[TBL] [Abstract][Full Text] [Related]
3. Kentucky Women's Justice Community Opioid Innovation Network (JCOIN): A type 1 effectiveness-implementation hybrid trial to increase utilization of medications for opioid use disorder among justice-involved women.
Staton M; Webster JM; Leukefeld C; Tillson M; Marks K; Oser C; Bush HM; Fanucchi L; Fallin-Bennett A; Garner BR; McCollister K; Johnson S; Winston E
J Subst Abuse Treat; 2021 Sep; 128():108284. PubMed ID: 33455828
[TBL] [Abstract][Full Text] [Related]
4. Health economic analyses of the justice community opioid innovation network (JCOIN).
Murphy SM; Laiteerapong N; Pho MT; Ryan D; Montoya I; Shireman TI; Huang E; McCollister KE
J Subst Abuse Treat; 2021 Sep; 128():108262. PubMed ID: 33419602
[TBL] [Abstract][Full Text] [Related]
5. Addressing opioid overdose deaths: The vision for the HEALing communities study.
Chandler RK; Villani J; Clarke T; McCance-Katz EF; Volkow ND
Drug Alcohol Depend; 2020 Dec; 217():108329. PubMed ID: 33075691
[TBL] [Abstract][Full Text] [Related]
6. The Opioid Crisis and the Future of Addiction and Pain Therapeutics.
Coussens NP; Sittampalam GS; Jonson SG; Hall MD; Gorby HE; Tamiz AP; McManus OB; Felder CC; Rasmussen K
J Pharmacol Exp Ther; 2019 Nov; 371(2):396-408. PubMed ID: 31481516
[TBL] [Abstract][Full Text] [Related]
7. Developing interagency collaboration to address the opioid epidemic: A scoping review of joint criminal justice and healthcare initiatives.
Yatsco AJ; Champagne-Langabeer T; Holder TF; Stotts AL; Langabeer JR
Int J Drug Policy; 2020 Sep; 83():102849. PubMed ID: 32653668
[TBL] [Abstract][Full Text] [Related]
8. Modernizing regulations for treating opioid use disorder during the COVID-19 pandemic.
Iacono TM
JAAPA; 2022 Feb; 35(2):57-59. PubMed ID: 35076441
[TBL] [Abstract][Full Text] [Related]
9. Economic Evaluation Design within the HEAL Prevention Cooperative.
Dunlap LJ; Kuklinski MR; Cowell A; McCollister KE; Bowser DM; Campbell M; Fernandes CF; Kemburu P; Livingston BJ; Prosser LA; Rao V; Smart R; Yilmazer T
Prev Sci; 2023 Oct; 24(Suppl 1):50-60. PubMed ID: 35947282
[TBL] [Abstract][Full Text] [Related]
10. Reducing Opioid Mortality in Illinois (ROMI): A case management/peer recovery coaching critical time intervention clinical trial protocol.
Pho M; Erzouki F; Boodram B; Jimenez AD; Pineros J; Shuman V; Claypool EJ; Bouris AM; Gastala N; Reichert J; Kelly M; Salisbury-Afshar E; Epperson MW; Gibbons RD; Schneider JA; Pollack HA
J Subst Abuse Treat; 2021 Sep; 128():108348. PubMed ID: 33745757
[TBL] [Abstract][Full Text] [Related]
11. A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report.
Crowley D; Delargy I
Harm Reduct J; 2020 Jul; 17(1):49. PubMed ID: 32680520
[TBL] [Abstract][Full Text] [Related]
12. HEAL Preventing Opioid Use Disorder: a Vision for Research to Increase Access to Prevention Services.
Goldstein AB; Oudekerk BA; Blanco C
Prev Sci; 2023 Oct; 24(Suppl 1):8-15. PubMed ID: 37603259
[TBL] [Abstract][Full Text] [Related]
13. Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic.
Cochran G; Bruneau J; Cox N; Gordon AJ
Subst Abus; 2020; 41(3):269-274. PubMed ID: 32697171
[TBL] [Abstract][Full Text] [Related]
14. Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis?
Doernberg M; Krawczyk N; Agus D; Fingerhood M
Subst Abus; 2019; 40(2):148-153. PubMed ID: 31008694
[TBL] [Abstract][Full Text] [Related]
15. Deploying science to change hearts and minds: Responding to the opioid crisis.
Walsh SL; Long KQX
Prev Med; 2019 Nov; 128():105780. PubMed ID: 31319116
[TBL] [Abstract][Full Text] [Related]
16. Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial.
Hser YI; Ober AJ; Dopp AR; Lin C; Osterhage KP; Clingan SE; Mooney LJ; Curtis ME; Marsch LA; McLeman B; Hichborn E; Lester LS; Baldwin LM; Liu Y; Jacobs P; Saxon AJ
Addict Sci Clin Pract; 2021 Apr; 16(1):24. PubMed ID: 33879260
[TBL] [Abstract][Full Text] [Related]
17. Take home injectable opioids for opioid use disorder during and after the COVID-19 Pandemic is in urgent need: a case study.
Oviedo-Joekes E; MacDonald S; Boissonneault C; Harper K
Subst Abuse Treat Prev Policy; 2021 Mar; 16(1):22. PubMed ID: 33673847
[TBL] [Abstract][Full Text] [Related]
18. The Opioid Epidemic During the COVID-19 Pandemic.
Haley DF; Saitz R
JAMA; 2020 Oct; 324(16):1615-1617. PubMed ID: 32945831
[No Abstract] [Full Text] [Related]
19. New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"?
Napoletano S; Basile G; Lo Faro AF; Negro F
Acta Biomed; 2022 May; 93(2):e2022186. PubMed ID: 35545997
[TBL] [Abstract][Full Text] [Related]
20. The role of neurologists in tackling the opioid epidemic.
Volkow ND; Koroshetz WJ
Nat Rev Neurol; 2019 May; 15(5):301-305. PubMed ID: 30792513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
